Ligand Pharmaceuticals LGND Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's common stock, shares authorized (in shares)?
- Ligand Pharmaceuticals (LGND) reported common stock, shares authorized (in shares) of $60M in Q1 2026.
- How has Ligand Pharmaceuticals's common stock, shares authorized (in shares) changed year-over-year?
- Ligand Pharmaceuticals's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $60M to $60M.
- What is the long-term trend for Ligand Pharmaceuticals's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's common stock, shares authorized (in shares) has grown at a 0.0% compound annual growth rate (CAGR), from $60M to $60M.